Live Breaking News & Updates on Lawrencew davis

Stay informed with the latest breaking news from Lawrencew davis on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lawrencew davis and stay connected to the pulse of your community

Structural inequities embedded in academic medicine persist across women's careers

Structural inequities embedded in academic medicine persist across women's careers
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Lawrencew-davis , Reshma-jagsi , National-academies , Emory-university-school-of-medicine , Emory-university-school , Oncology-peer-perspective-board ,

Dr Jagsi on the Feasibility of Radiation Omission Following Surgery in Breast Cancer Care

Reshma Jagsi, MD, DPhil, discusses 5-year findings from the IDEA trial assessing radiotherapy omission for postmenopausal patients with breast cancer.

Lawrencew-davis , Reshma-jagsi , Department-of-radiation-oncology , Emory-university-school-of-medicine , Radiation-oncology , Emory-university-school , Inship-cancer-institute-of-emory-university , Onclive-tv , Breast-cancer , Sabcs , Radiation , Surgery

Currently Enrolling Trial Examines Innovative Approach in Inflammatory Breast Cancer

The S1706 study is currently enrolling patients with inflammatory breast cancer to determine if adding a PARP inhibitor to radiation therapy is effective.

France , Georgia , United-states , Atlanta , Emory-university , French , Reshma-jagsi , Lawrencew-davis , Translational-breast-cancer-research-consortium , Radiation-oncology , Emory-university-school , Translational-breast-cancer-research

Gender differences persist in academic mentorship, sponsorship in well-established faculty

Gender differences persist in academic mentorship, sponsorship in well-established faculty
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Lawrencew-davis , Reshma-jagsi , Emory-university-school-of-medicine , Twitter , Emory-university-school , Oncology-peer-perspective-board ,

Jagsi Holds a Magnifying Glass to Radiation Oncology: Uncovering Key Disparities and When to Omit Radiation in Breast Cancer

Investigating when radiation therapy can be appropriately omitted and striving to uncover disparities are areas of focus in the field of radiation oncology.

Georgia , United-states , Emory-university , Miami , Florida , Atlanta , San-antonio , Texas , American , Americans , Reshma-jagsi , Juliar-white

Omission in Breast Cancer: When to Leave Radiation Behind and How to Mitigate Disparities

Reshma Jagsi, MD, DPhil, details advances from 2023 in breast cancer radiation oncology and interventions aimed at combating disparities within oncology.

San-antonio , Texas , United-states , Atlanta , Georgia , Emory-university , Reshma-jagsi , Lawrencew-davis , Doris-duke-charitable-foundation , Fund-to-retain-clinical-scientists-program , Retain-clinical-scientists-program , Radiation-oncology

Omitting Radiation Therapy From Breast Cancer Treatment May Be Possible for Younger Post-Menopausal Women With Early-Stage HR-Positive/HER2-Negative Breast Cancer

A clinical trial suggests younger post-menopausal women with early-stage HR-positive/HER2-negative breast cancer may safely omit radiation therapy if they continue endocrine therapy.

San-antonio , Texas , United-states , Reshma-jagsi , Lawrencew-davis , Emory-university-school-of-medicine , San-antonio-breast-cancer-symposium , Radiation-oncology , Emory-university-school , Winship-cancer-institute , Emory-university ,

IDEA trial: Skipping radiotherapy safe for younger postmenopausal patients with early-stage breast cancer

Almost all postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years after surgery, according to results from the IDEA clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

San-antonio , Texas , United-states , American , Lawrencew-davis , Reshma-jagsi , Emory-university-school-of-medicine , Doris-duke-foundation , Winship-cancer-institute-of-emory-university , University-of-michigan-rogel-cancer-center , American-cancer-society , Susang-komen-breast-cancer-foundation

Some younger women with early breast cancer may be able to omit adjuvant radiotherapy

Some younger women with early breast cancer may be able to omit adjuvant radiotherapy
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

San-antonio , Texas , United-states , Byjennifer-southall , Lawrencew-davis , Mindy-valcarcel , Reshma-jagsi , Oncotype-dx-exact-sciences , Emory-university-school-of-medicine , San-antonio-breast-cancer , Emory-university-school , Exact-sciences

Younger postmenopausal patients with early-stage breast cancer may be able to safely omit adjuvant radiotherapy

Younger postmenopausal patients with early-stage breast cancer may be able to safely omit adjuvant radiotherapy
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

San-antonio , Texas , United-states , Lawrencew-davis , Reshma-jagsi , Emory-university-school-of-medicine , Winship-cancer-institute-of-emory-university , San-antonio-breast-cancer-symposium , Emory-university-school , Winship-cancer-institute , Genomic-risk , Year-outcomes